Bullous erysipelas: Clinical presentation, staphylococcal involvement and methicillin resistance

被引:24
作者
Krasagakis, K [1 ]
Samonis, G
Maniatakis, P
Georgala, S
Tosca, A
机构
[1] Univ Hosp Heraklion, Dept Dermatol, GR-71110 Iraklion, Greece
[2] Univ Hosp Heraklion, Dept Internal Med, GR-71110 Iraklion, Greece
[3] Univ Athens, Dept Dermatol, A Sygros Hosp, Athens, Greece
关键词
erysipelas; bullous; Staphylococcus aureus; methicillin resistance;
D O I
10.1159/000089019
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background: Erysipelas is a bacterial infection of the dermis and hypodermis, mostly of streptococcal origin. Bullous erysipelas represents a severe form of the disease. Objective: To evaluate the clinical and microbiological characteristics and treatment of bullous erysipelas. Methods: Patients with a diagnosis of bullous erysipelas who were treated at the Department of Dermatology, University Hospital of Heraklion, Crete, Greece, between the years 1996 and 2001 were retrospectively studied. Results: Fourteen patients ( 11 women, 3 men) with bullous erysipelas were evaluated. The lesions were located on the legs and face in 9 and 4 patients, respectively. The median duration of disease before hospital admission was 4 days. Eight patients had fever at presentation. Local trauma and various lesions were common causes for pathogen entry. The initial empirical antibiotic treatment included intravenous beta-lactams and was modified according to the sensitivities of the isolated strains. Staphylococcus aureus was isolated from 7 (50%), while S. warneri, Streptococcus pyogenes and Escherichia coli grew from the lesions of 3 other patients. Six out of 7 S. aureus strains were methicillin resistant (MRSA) but susceptible to several other non-beta-lactam antibiotics such as quinolones, vancomycin, rifampicin and trimethoprim/sulfamethoxazole. Conclusion: Our findings suggest that S. aureus is frequently involved in and probably contributes in synergy with beta-hemolytic streptococci to the complicated course of bullous erysipelas. The frequency of MRSA isolation suggests that beta-lactam antibiotics may not be sufficient for the treatment of bullous erysipelas anymore, at least in areas with a high incidence of MRSA strains. The role of other classes of antibiotics providing adequate coverage for MRSA has to be evaluated in prospective clinical trials. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 19 条
[1]   STREPTOCOCCAL CAUSE OF ERYSIPELAS AND CELLULITIS IN ADULTS - A MICROBIOLOGIC STUDY USING A DIRECT IMMUNOFLUORESCENCE TECHNIQUE [J].
BERNARD, P ;
BEDANE, C ;
MOUNIER, M ;
DENIS, F ;
CATANZANO, G ;
BONNETBLANC, JM .
ARCHIVES OF DERMATOLOGY, 1989, 125 (06) :779-782
[2]   RECURRENT ERYSIPELAS CAUSED BY GROUP-B STREPTOCOCCUS ORGANISMS [J].
BINNICK, AN ;
KLEIN, RB ;
BAUGHMAN, RD .
ARCHIVES OF DERMATOLOGY, 1980, 116 (07) :798-799
[3]   ERYSIPELAS [J].
CHARTIER, C ;
GROSSHANS, E .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 1990, 29 (07) :459-467
[4]   Community-acquired methicillin-resistant Staphylococcus aureus skin infection:: An emerging clinical problem [J].
Cohen, PR ;
Kurzrock, R .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2004, 50 (02) :277-280
[5]  
Dornbusch K, 1998, SCAND J INFECT DIS, V30, P281, DOI 10.1080/00365549850160945
[6]   Risk factors for erysipelas of the leg (cellulitis): case-control study [J].
Dupuy, A ;
Benchikhi, H ;
Roujeau, JC ;
Bernard, P ;
Vaillant, L ;
Chosidov, O ;
Sassolas, B ;
Guillaume, JC ;
Grob, JJ ;
Bastuji-Garin, S .
BRITISH MEDICAL JOURNAL, 1999, 318 (7198) :1591-1594
[7]   Staphylococcal resistance revisited:: community-acquired methicillin resistant Staphylococcus aureus -: an emerging problem for the management of skin and soft tissue infections [J].
Eady, EA ;
Cove, JH .
CURRENT OPINION IN INFECTIOUS DISEASES, 2003, 16 (02) :103-124
[8]   Erysipelas: Clinical and bacteriologic spectrum and serological aspects [J].
Eriksson, B ;
JorupRonstrom, C ;
Karkkonen, K ;
Sjoblom, AC ;
Holm, SE .
CLINICAL INFECTIOUS DISEASES, 1996, 23 (05) :1091-1098
[9]   Anal colonization of group G β-hemolytic streptococci in relapsing erysipelas of the lower extremity [J].
Eriksson, BKG .
CLINICAL INFECTIOUS DISEASES, 1999, 29 (05) :1319-1320
[10]   Bullous erysipelas: A retrospective study of 26 patients [J].
Guberman, D ;
Gilead, LT ;
Zlotogorski, A ;
Schamroth, J .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 1999, 41 (05) :733-737